Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens by Danilo De Novellis, Raffaele Fontana, Bianca Serio, Emilia Vaccaro, Roberto Guariglia, Denise Morini, Michela Rizzo, Valentina Giudice, Carmine Selleri

Get full text